Physician profile
Gabriel Lopez
NPI 1801814165
$15,008.53
in general payments reported to CMS, 2019-2025
11 companies · $4,038 in 2025
The $4,038 reported for 2025 was more than what 89% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,742 · 2020: $2,827 · 2021: $1,131 · 2022: $1,072 · 2023: $1,851 · 2024: $1,348 · 2025: $4,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,237.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,634.22 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $2,004.87 | 2019-2022 | |
| Biotronik Nro, INC. | $1,813.73 | 2025 | Prospera |
| Stratus Medical, LLC | $554.35 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $373.93 | 2024-2025 | |
| Spr Therapeutics, INC | $202.13 | 2024-2025 | Sprint Pns System |
| Horizon Therapeutics Plc | $161.13 | 2019-2022 | |
| Genesys Orthopedics Systems, L.L.C. | $120.21 | 2025 | Sacroiliac Joint Fusion System |
| Medtronic, INC. | $56.09 | 2025 | Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.97 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.